These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Agoraphobia and panic disorder: treatment with alprazolam. Mark SL Tex Med; 1984 Oct; 80(10):50-2. PubMed ID: 6150561 [No Abstract] [Full Text] [Related]
23. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines. Chouinard G; Labonte A; Fontaine R; Annable L Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609 [TBL] [Abstract][Full Text] [Related]
24. Preliminary evidence for the utility of carbamazepine in alprazolam withdrawal. Klein E; Uhde TW; Post RM Am J Psychiatry; 1986 Feb; 143(2):235-6. PubMed ID: 2868666 [TBL] [Abstract][Full Text] [Related]
25. [New proposals for the development of the concepts of neurotic anxiety, major depression and panic attack]. Xhenseval B Acta Psychiatr Belg; 1985; 85(4):480-508. PubMed ID: 2865869 [TBL] [Abstract][Full Text] [Related]
26. A controlled clinical trial of alprazolam for the treatment of anxiety. Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927 [TBL] [Abstract][Full Text] [Related]
27. Let's talk facts about anxiety disorders. American Psychiatric Association J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997 [No Abstract] [Full Text] [Related]
30. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder. Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686 [TBL] [Abstract][Full Text] [Related]
31. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study. Chouinard G; Annable L; Fontaine R; Solyom L Psychopharmacology (Berl); 1982; 77(3):229-33. PubMed ID: 6126907 [TBL] [Abstract][Full Text] [Related]
32. Psychopharmacology of the anxiety disorders. Ballenger JC Psychiatr Clin North Am; 1984 Dec; 7(4):757-71. PubMed ID: 6151647 [TBL] [Abstract][Full Text] [Related]
36. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy. Carr DB; Sheehan DV; Surman OS; Coleman JH; Greenblatt DJ; Heninger GR; Jones KJ; Levine PH; Watkins WD Am J Psychiatry; 1986 Apr; 143(4):483-94. PubMed ID: 2869703 [TBL] [Abstract][Full Text] [Related]
37. Chronic anxiety: deciding the length of treatment. Gorman JM; Papp LA J Clin Psychiatry; 1990 Jan; 51 Suppl():11-5. PubMed ID: 1967247 [TBL] [Abstract][Full Text] [Related]
38. The assessment and treatment of refractory anxiety. Hollander E; Cohen LJ J Clin Psychiatry; 1994 Feb; 55 Suppl():27-31. PubMed ID: 7915712 [TBL] [Abstract][Full Text] [Related]
39. [Is there a specific pharmacological treatment for anxiety disorders? Summary of a controversy]. Todorov C Sante Ment Que; 2004; 29(1):127-36. PubMed ID: 15470568 [TBL] [Abstract][Full Text] [Related]